Galectin Therapeutics Inc.
Galectin Therapeutics Inc. (GALT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · GALT · as of Jun 8, 2026
Activity summary
Buy transactions
5
P-Purchase only
Sell transactions
51
12 Months
Buy/Sell ratio
0.10
Buy/Sell (by trades)
Overall sentiment
Galectin Therapeutics Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
GALT insider buying and selling by quarter
GALT insider selling · GALT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · GALT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
GALT executive sell shares · GALT board member insider trading · GALT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 26, 2026 | Jamil Khurram Chief Medical Officer | Option | 568 | $699 | Form 4 |
| May 26, 2026 | Jamil Khurram Chief Medical Officer | Sale | 568 | $2K | Form 4 |
| Feb 6, 2026 | ELDRED KARY Director | Purchase | 300 | $810 | Form 4 |
| Jan 16, 2026 | Uihlein Richard E Director | Award | 13,158 | $40K | Form 4 |
| Jan 5, 2026 | LEWIS JOEL President and CEO · Director | Other | 56,332 | $219K | Form 4 |
| Jan 2, 2026 | LEWIS JOEL President and CEO · Director | Option | 84,000 | — | Form 4 |
| Jan 2, 2026 | LEWIS JOEL President and CEO · Director | Sale | 18,571 | $78K | Form 4 |
| Jan 5, 2026 | LEWIS JOEL President and CEO · Director | Sale | 27,731 | $108K | Form 4 |
| Jan 6, 2026 | LEWIS JOEL President and CEO · Director | Sale | 37,698 | $135K | Form 4 |
| Jan 2, 2026 | CALLICUTT JACK W CFO | Option | 60,000 | — | Form 4 |
| Jan 2, 2026 | CALLICUTT JACK W CFO | Sale | 13,914 | $58K | Form 4 |
| Jan 5, 2026 | CALLICUTT JACK W CFO | Sale | 25,732 | $100K | Form 4 |
| Jan 6, 2026 | CALLICUTT JACK W CFO | Sale | 20,354 | $75K | Form 4 |
| Jan 2, 2026 | Jamil Khurram Chief Medical Officer | Option | 60,000 | — | Form 4 |
| Jan 2, 2026 | Jamil Khurram Chief Medical Officer | Sale | 13,055 | $55K | Form 4 |
| Jan 6, 2026 | Jamil Khurram Chief Medical Officer | Sale | 21,446 | $78K | Form 4 |
| Dec 31, 2025 | Jamil Khurram Chief Medical Officer | Option | 8,125 | $10K | Form 4 |
| Dec 31, 2025 | Jamil Khurram Chief Medical Officer | Sale | 8,125 | $33K | Form 4 |
| Dec 23, 2025 | FREEMAN KEVIN D Director | Purchase | 5,500 | $20K | Form 4 |
| Dec 23, 2025 | ELDRED KARY Director | Purchase | 700 | $3K | Form 4 |
| Dec 17, 2025 | LEWIS JOEL President and CEO · Director | Option | 7,829 | $22K | Form 4 |
| Dec 17, 2025 | LEWIS JOEL President and CEO · Director | Sale | 7,829 | $55K | Form 4 |
| Dec 17, 2025 | Jamil Khurram Chief Medical Officer | Option | 8,500 | $21K | Form 4 |
| Dec 17, 2025 | Jamil Khurram Chief Medical Officer | Option | 6,463 | $14K | Form 4 |
| Dec 17, 2025 | Jamil Khurram Chief Medical Officer | Sale | 8,500 | $60K | Form 4 |
Jamil Khurram
Chief Medical Officer
Date
May 26
Shares
568
Price
$1.23
Value
$699
LEWIS JOEL
President and CEO · Director
Date
Jan 5
Shares
56,332
Price
$3.88
Value
$219K
LEWIS JOEL
President and CEO · Director
Date
Jan 2
Shares
18,571
Price
$4.20
Value
$78K
LEWIS JOEL
President and CEO · Director
Date
Jan 5
Shares
27,731
Price
$3.91
Value
$108K
LEWIS JOEL
President and CEO · Director
Date
Jan 6
Shares
37,698
Price
$3.58
Value
$135K
Jamil Khurram
Chief Medical Officer
Date
Jan 2
Shares
13,055
Price
$4.20
Value
$55K
Jamil Khurram
Chief Medical Officer
Date
Jan 6
Shares
21,446
Price
$3.65
Value
$78K
Jamil Khurram
Chief Medical Officer
Date
Dec 31
Shares
8,125
Price
$1.23
Value
$10K
Jamil Khurram
Chief Medical Officer
Date
Dec 31
Shares
8,125
Price
$4.07
Value
$33K
LEWIS JOEL
President and CEO · Director
Date
Dec 17
Shares
7,829
Price
$2.86
Value
$22K
LEWIS JOEL
President and CEO · Director
Date
Dec 17
Shares
7,829
Price
$7.06
Value
$55K
Jamil Khurram
Chief Medical Officer
Date
Dec 17
Shares
8,500
Price
$2.50
Value
$21K
Jamil Khurram
Chief Medical Officer
Date
Dec 17
Shares
6,463
Price
$2.20
Value
$14K
Jamil Khurram
Chief Medical Officer
Date
Dec 17
Shares
8,500
Price
$7.04
Value
$60K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About GALT insider trading
GALT insider trades
Galectin Therapeutics Inc. (GALT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Shlevin Harold H. (Director), LEWIS JOEL (President and CEO · Director), Jamil Khurram (Chief Medical Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. GALT insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Galectin Therapeutics Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
GALT insider trading · 5 questionsThe insiders of Galectin Therapeutics Inc. (GALT) include executives and directors such as Shlevin Harold H. (Director), LEWIS JOEL (President and CEO · Director), Jamil Khurram (Chief Medical Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026